Inventor · disambiguated record
Katja Zimmermann
Also filed as: ZIMMERMANN KATJA
43 granted patents·17 pending applications·172 citations·filing 2008–2023
97Inventor score
Top patents by PatentIndex Score
60 records- 0194US11130745B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2020·Granted Sep 28, 2021·4 cites·19 claims
- 0294US10300062B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2018·Granted May 28, 2019·11 cites·21 claims
- 0393US9949978B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·42 claims
- 0493US9949977B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·19 claims
- 0593US9481672B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2013·Granted Nov 1, 2016·18 cites·44 claims
- 0689US10815215B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2017·Granted Oct 27, 2020·5 cites·20 claims
- 0788US9957235B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted May 1, 2018·8 cites·34 claims
- 0888US8426602B2Heteroaryl-substituted dicyanopyridines and their useMEIBOM DANIEL·Filed 2009·Granted Apr 23, 2013·24 cites·5 claims
- 0988US8119663B2Heteroaryl-substituted piperidinesHEIMBACH DIRK·Filed 2008·Granted Feb 21, 2012·16 cites·8 claims
- 1087US11713304B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2021·Granted Aug 1, 2023·1 cites·11 claims
- 1186US10179123B22-aryl- and 2-arylalkyl-benzimidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Jan 15, 2019·4 cites·15 claims
- 1286US9951027B2Benzimidazol-2-amines as MIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted Apr 24, 2018·8 cites·22 claims
- 1385US10138226B2Benzimidazol-2-amines as MIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·6 cites·29 claims
- 1485US8420825B2Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugsVAKALOPOULOS ALEXANDROS·Filed 2010·Granted Apr 16, 2013·10 cites·29 claims
- 1584US10968216B24,5-annulated 1,2,4-triazolonesBAYER AG·Filed 2017·Granted Apr 6, 2021·3 cites·16 claims
- 1683US8772498B2Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereofBAYER IP GMBH·Filed 2013·Granted Jul 8, 2014·5 cites·7 claims
- 1782US8440700B2Substituted aryloxazoles and their useNELL PETER·Filed 2008·Granted May 14, 2013·6 cites·5 claims
- 1879US10137110B21-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumorsBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·4 cites·29 claims
- 1978US12486248B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2023·Granted Dec 2, 2025·0 cites·21 claims
- 2075US10370339B2N-Methylbenzimidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Aug 6, 2019·2 cites·15 claims
- 2175US9695131B2Substituted uracils as chymase inhibitorsBayer Pharma AG·Filed 2014·Granted Jul 4, 2017·2 cites·4 claims
- 2275US8741834B2Dipeptoid prodrugs and the use thereofLERCHEN HANS-GEORG·Filed 2009·Granted Jun 3, 2014·2 cites·8 claims
- 2374US9751843B2Substituted uracils and use thereofBayer Pharma AG·Filed 2014·Granted Sep 5, 2017·2 cites·10 claims
- 2474US8987248B2Substituted piperidines as Par-1 antagonistsJESKE MARIO·Filed 2010·Granted Mar 24, 2015·1 cites·9 claims
- 2574US8084469B2Substituted piperidinesHEIMBACH DIRK·Filed 2010·Granted Dec 27, 2011·3 cites·17 claims
- 2672US8202862B2Substituted piperidinesHEIMBACH DIRK·Filed 2010·Granted Jun 19, 2012·2 cites·27 claims
- 2769US10414734B25-hydroxyalkylbenzimidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Sep 17, 2019·1 cites·16 claims
- 2865US2020061063A1Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2019·Application pending·0 cites
- 2959US11787797B24,5-annulated 1,2,4-triazolonesBAYER AG·Filed 2021·Granted Oct 17, 2023·0 cites·2 claims
- 3059US2025302837A1Inhibitors of chymase for use in the selective resolution of thrombi in thrombotic or thromboembolic disordersSOCPRA SCIENCES SANTE ET HUMAINES S E C·Filed 2023·Application pending·0 cites
- 3158US2014296515A1Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereofBAYER IP GMBH·Filed 2014·Application pending·0 cites
- 3254US9205077B22-alkoxy-substituted dicyanopyridines and their useBAYER IP GMBH·Filed 2014·Granted Dec 8, 2015·0 cites·8 claims
- 3354US8791146B22-alkoxy-substituted dicyanopyridines and their useHübsch Walter·Filed 2009·Granted Jul 29, 2014·0 cites·9 claims
- 3453US9095582B2Substituted aryloxazoles and their useBAYER IP GMBH·Filed 2013·Granted Aug 4, 2015·0 cites·5 claims
- 3553US2011237629A1Amino acid ester prodrugs and the use thereofBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 3651US10442772B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2018·Granted Oct 15, 2019·0 cites·21 claims
- 3751US9187428B2Substituted dicyanopyridines and use thereofVAKALOPOULOS ALEXANDROS·Filed 2011·Granted Nov 17, 2015·0 cites·5 claims
- 3850US8618119B2Fused cyanopyridines and the use thereofNELL PETER·Filed 2008·Granted Dec 31, 2013·0 cites·9 claims
- 3950US2011021487A1Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and their useBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 4050US2015183773A1Substituted piperidinesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 4149US8642595B2Annellated 4-(indazolyl)-1,4-dihydropyridine derivatives and methods of use thereofMICHELS MARTIN·Filed 2009·Granted Feb 4, 2014·0 cites·19 claims
- 4249US8551989B2Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereofMICHELS MARTIN·Filed 2009·Granted Oct 8, 2013·0 cites·20 claims
- 4349US8440657B2Substituted piperidinesHEIMBACH DIRK·Filed 2010·Granted May 14, 2013·0 cites·23 claims
- 4448US2017267648A1Substituted uracils as chymase inhibitorsBayer Pharma AG·Filed 2017·Application pending·0 cites
- 4548US2022411381A1Pyrimidinedione derivativesBAYER AG·Filed 2020·Application pending·0 cites
- 4646US2016287599A1Substituted 1,2,4-triazine-3,5-diones and the use thereof as chymase inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4745US2016311812A1Adenosine a1 agonists as medicaments for kidney disordersBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4845US2012214788A1Heteroaryl-substituted piperidinesHEIMBACH DIRK·Filed 2012·Application pending·0 cites
- 4941US9073939B2Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereofMICHELS MARTIN·Filed 2010·Granted Jul 7, 2015·0 cites·8 claims
- 5041US2012220563A1Substituted piperidinesHEIMBACH DIRK·Filed 2010·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →